Lieke H. van Huis‐Tanja

Author

Also Known As

L H van Huis-Tanja, L. H. van Huis-Tanja, L.H. van Huis-Tanja, Lieke H van Huis-Tanja, Lieke H. Huis‐Tanja, Lieke H. van Huis-Tanja, Lieke H. van Huis‐Tanja

Publications

312

Citations

H-Index

Concepts

All Affiliations

Diakonessenhuis hospital University Medical Center Utrecht Netherlands Comprehensive Cancer Organisation University of Amsterdam Leiden University Medical Center

About

Lieke H. van Huis‐Tanja is an author at Diakonessenhuis hospital specializing in medicine, family medicine, and geriatric oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	132
2	Public Health	3	3	59
3	Nursing	1	1	21
4	Cell Biology	1	1	13
5	Epidemiology	1	1	29

Lieke H. van Huis‐Tanja

Publications

263

Citations

H-Index

Page 1

	Year	Citations
Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing André B. P. Kuilenburg, Judith Meijer, Dirk Maurer, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Severe Fluoropyrimidine ToxicityDrug ResistanceMrna SplicingMolecular BiologyPathology	2016	43
Treatment decision-making in elderly women with ovarian cancer: an age-based comparison Inez Charlotte van Walree, Neeltje J. van Soolingen, Marije E. Hamaker, International Journal of Gynecological Cancer	2019	29
Development of a self-reported version of the G8 screening tool Inez Charlotte van Walree, Ariël M. Vondeling, Geraldine R. Vink, Journal of Geriatric Oncology Cancer ScreeningMedicineDiagnostic CriterionDiagnostic TestDiagnosis	2019	29
Clinical judgment versus geriatric assessment for frailty in older patients with cancer Inez Charlotte van Walree, Ellen R. M. Scheepers, Frederiek van den Bos, Journal of Geriatric Oncology Family MedicineGeriatric OncologyAgingGeriatricsLongevity	2020	26
MTHFR polymorphisms and capecitabine-induced toxicity in patients with metastatic colorectal cancer Lieke H. van Huis‐Tanja, Hans Gelderblom, Cornelis J.A. Punt, Pharmacogenetics and Genomics	2013	21
What Defines Quality of Life for Older Patients Diagnosed with Cancer? A Qualitative Study Nelleke Seghers, Jolina A. Kregting, Lieke H. van Huis‐Tanja, Cancers Quality Of LifeFamily MedicineLife AssessmentAgingA Qualitative Study	2022	21
Older ovarian cancer survivors report lower long-term health-related quality of life than younger survivors: A study from the population-based profiles registry Inez Charlotte van Walree, Marije E. Hamaker, Lonneke V. van de Poll‐Franse, Gynecologic Oncology Quality Of LifeFamily MedicineGeriatric OncologyAgingCancer Epidemiology	2019	16
Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS) Patricia A. H. Hamers, Geraldine R. Vink, Marloes A.G. Elferink, Clinical Colorectal Cancer	2022	16
Reasons for guideline non-adherence in older and younger women with advanced stage ovarian cancer Inez Charlotte van Walree, Reini Bretveld, Lieke H. van Huis‐Tanja, Gynecologic Oncology Family MedicineGeriatric OncologyGeriatricsMedicineCancer Management	2020	14
Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin Lieke H. van Huis‐Tanja, Dina M. Kweekel, Xiaobo Lu, Mutation research. Fundamental and molecular mechanisms of mutagenesis ChromatinGenome InstabilityC118t SnpChromatin RemodelingGenetics	2013	13

Page 1